BECTON DICKINSON & CO

BDX · XNYS

CIK 10795fmd_1SH2S7F0C6PSNAT179T5ZVD7RWManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Oct 01, 2006 to Jun 30, 2026, 74 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	12,483	12,093	15,983	17,290	16,074	19,131	18,870	19,372	20,178	21,840
Cost of revenue	6,492	6,128	8,714	9,002	9,276	10,500	10,393	11,202	11,053	11,915
Gross profit	5,991	5,942	7,269	8,288	7,577	8,631	8,477	8,170	9,125	9,925
Research and development	828	770	1,004	1,062	1,039	1,279	1,256	1,237	1,190	1,265
Selling, general and administrative	3,005	2,909	4,016	4,332	4,185	4,719	4,709	4,719	4,857	5,278
Operating income	1,430	1,522	1,509	1,760	912	2,250	2,282	2,111	2,397	2,579
Interest expense	388	521	706	639	528	469	398	452	528	613
Interest and investment income	21	76	65	12	7	9	16	49	163	38
Other non-operating income (expense)	11	(101)	305	43	23	(99)	(117)	(46)	(28)	(123)
Income before taxes	1,074	976	1,173	1,176	414	1,692	1,783	1,662	2,005	1,881
Income tax expense	97	(124)	862	(57)	62	88	148	132	300	203
Net income from continuing operations	977	1,100	311	1,233	352	1,604	1,635	1,530	1,705	1,678
Net income	976	1,100	311	1,233	874	2,092	1,779	1,484	1,705	1,678
Net income to common shareholders	976	1,030	159	1,082	767	2,002	1,689	1,424	1,705	1,678